Emotion processing in schizophrenia: fMRI study of patients treated with risperidone long-acting injections or conventional depot medication

J Psychopharmacol. 2011 Jun;25(6):722-33. doi: 10.1177/0269881110363316. Epub 2010 Apr 1.

Abstract

We employed two event-related functional magnetic resonance imaging tasks using the pictures of mild and intense facial emotions of fear or happiness. The sample comprised 16 chronic schizophrenia patients treated with risperidone long-acting injections (RLAI), 16 patients treated with conventional antipsychotic depots (CONV) and 16 healthy controls (HC). The HC and RLAI groups demonstrated greater activation in the left amygdala in response to intensively fearful faces, and in right cerebellum to intensively happy faces compared with CONV patients. The CONV group demonstrated under-activation in the right temporal pole in response to intensively happy faces (compared with HC) and over-activation in ventro-medial prefrontal cortex (VMPFC) in response to both intensively happy and fearful expressions, compared with HC and RLAI groups. Our results suggest that networks implicated in the allocation of attentional resources (VMPFC) and emotion processing (amygdala, cerebellum) are differentially affected in patients on CONV versus RLAI.

Publication types

  • Controlled Clinical Trial

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Antipsychotic Agents / administration & dosage
  • Antipsychotic Agents / pharmacology*
  • Antipsychotic Agents / therapeutic use
  • Attention / drug effects
  • Attention / physiology
  • Brain / drug effects
  • Brain / physiopathology
  • Brain Mapping / methods
  • Delayed-Action Preparations / administration & dosage
  • Delayed-Action Preparations / therapeutic use
  • Emotions / drug effects*
  • Emotions / physiology*
  • Facial Expression
  • Humans
  • Magnetic Resonance Imaging / methods
  • Male
  • Middle Aged
  • Photic Stimulation
  • Psychomotor Performance / drug effects
  • Psychomotor Performance / physiology
  • Risperidone / administration & dosage
  • Risperidone / pharmacology*
  • Risperidone / therapeutic use
  • Schizophrenia / drug therapy*
  • Schizophrenia / physiopathology*
  • Schizophrenic Psychology*

Substances

  • Antipsychotic Agents
  • Delayed-Action Preparations
  • Risperidone